05/09/2024 | Press release | Distributed by Public on 05/08/2024 21:02
Osaka, Japan, May 9, 2024 - Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Toichi Takino; "the Company") today announced that there were differences in the non-consolidated financial results (Japanese standard) between the fiscal year ended March 2024 (April 1, 2023 to March 31, 2024) and the previous fiscal year.
(Unit: Millions of yen, except basic earnings per share)
Revenues |
Operating Profit |
Ordinary Profit |
Net Profit for the year |
Basic earnings |
|
Previous Results (A) |
441,242 |
152,004 |
150,755 |
117,190 |
239.96 |
Actual Results (B) |
498,777 |
187,916 |
188,036 |
152,909 |
318.51 |
Change(B-A) |
57,535 |
35,912 |
37,280 |
35,719 |
- |
Change(%) |
13.0 |
23.6 |
24.7 |
30.5 |
- |